Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RYKINDO® safely and effectively. See full prescribing information for RYKINDO®. RYKINDO® (risperidone) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 1993
Medication labelWhy this: Advisory · dailymed-prescription
RYKINDO is indicated: for the treatment of schizophrenia in adults as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults
- generic_name
- risperidone
- brand_name
- Diluent
- product_names
- Risperidone, Diluent
- ndc
- 72526-101, 72526-102, 72526-103, 72526-104, 72526-101-11, 72526-201, 72526-201-01, 72526-801, 72526-801-01, 72526-102-11, 72526-202, 72526-202-01, 72526-103-11, 72526-203, 72526-203-01, 72526-104-11, 72526-204, 72526-204-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en